Integra LifeSciences enters $50M accelerated share repurchase with Morgan Stanley

INTEGRA LIFESCIENCES HOLDINGS CORP

Signed ASR agreement on May 16, 2024 with Morgan Stanley & Co. LLC.
Repurchase covers $50M of common stock (par value $0.01).
Transaction expected to be completed in the third quarter of 2024.

item 8.01

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0000917520-24-000074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.